Federal Register / Vol. 72, No.

134 / Friday, July 13, 2007 / Notices 38599

these activities elicit the desired effects • Toxicology Curriculum for an appropriate technological format and
or impact. Communities Training Manual whether they meet the needs, wants,
ATSDR is requesting a reinstatement User Satisfaction Survey (TCCUS) and preferences of visitors to the
with minor changes for the following • ToxProfilesTM CD–ROM User ATSDR Web site. The survey questions
customer satisfaction surveys: Satisfaction Survey (TP–CDUS) have been held to the absolute
• ATSDR Web Site User Satisfaction The results of this project will ensure
minimum required for the use of the
Survey (WSUS) that these audiences will continue to
data.
• Toxicological Profiles User find our knowledge products and
Satisfaction Survey (TPUS) informational pieces easy to access, This extension request is for a three-
• ToxFAQsTM User Satisfaction clear, informative and useful. year period. There are no costs to the
Survey (TFUS) Specifically, this project will continue respondents other than their time. The
• Public Health Statements User to examine whether current and future total estimated annualized burden hours
Satisfaction Survey (PHSUS) informational updates are presented in are 166.

ESTIMATED ANNUALIZED BURDEN HOURS

Average bur-
Number of
Number of den
Type of respondents Form name responses per
respondents per response
respondent (in hours)

ATSDR Web site Visitors ................................ WSUS ............................................................. 1000 1 5/60

TPUS .............................................................. 300 1 5/60
TFUS .............................................................. 300 1 5/60
PHSUS ........................................................... 100 1 5/60
TCCUS ........................................................... 160 1 5/60
TP–CDUS ....................................................... 140 1 5/60

Dated: July 9, 2007. comments should be received within 30 voluntary and provides the respondents
Maryam I. Daneshvar, days of this notice. an opportunity to (1) assure accurate
Acting Reports Clearance Officer, Centers for tests are being provided by the
Proposed Project
Disease Control and Prevention. laboratory/testing site through external
[FR Doc. E7–13597 Filed 7–12–07; 8:45 am] CDC Model Performance Evaluation quality assessment; (2) improve testing
BILLING CODE 4163–18–P
Program (MPEP) (0920–0274)— quality through self-evaluation in a non-
Revision—National Center for regulatory environment; (3) test well
Preparedness, Detection, and Control of characterized samples from a source
DEPARTMENT OF HEALTH AND Infectious Diseases (proposed) outside the test kit manufacturer; (4)
HUMAN SERVICES (NCPDCID), Centers for Disease Control discover potential testing problems so
and Prevention (CDC). that procedures can be adjusted to
Centers for Disease Control and eliminate them; (5) compare of testing
Background and Brief Description
Prevention results with others at a national and
CDC is requesting OMB approval of a international level; and (6) consult with
[30Day–07–0274] revision to its data collection, the CDC CDC staff to discuss testing issues.
Model Performance Evaluation Program In this request, CDC proposes to make
Agency Forms Undergoing Paperwork (MPEP). CDC originally implemented the following revisions to the currently
Reduction Act Review MPEP in 1986 to evaluate the approved data collection:
performance of laboratories conducting • Addition of a Name and Address
The Centers for Disease Control and testing to detect human change form to report changes for the
Prevention (CDC) publishes a list of immunodeficiency virus type 1 (HIV–1) MPEP manager and coordinator at the
information collection requests under antibody (Ab). CDC is requesting a 3- respondent laboratory;
review by the Office of Management and year approval for this data collection. • Inclusion of additional test kit
Budget (OMB) in compliance with the In this program, respondents receive 2 manufacturers approved by the FDA
Paperwork Reduction Act (44 U.S.C. shipments of specimens per year. since previous OMB approval; and
Chapter 35). To request a copy of these Respondents test the specimens in their • Elimination of reporting HIV–1
requests, call the CDC Reports Clearance laboratory/testing site and report their RNA Viral Load and CD4+ T-cell
Officer at (404) 639–5960 or send an results either using a report booklet or determinations.
e-mail to omb@cdc.gov. Send written on-line. CDC provides the respondent There are no costs to the respondents
comments to CDC Desk Officer, Office of with a report containing the analysis of other than their time to complete the
Management and Budget, Washington, the laboratory test results reported to survey. The total estimated annualized
DC or by fax to (202) 395–6974. Written CDC. Participation in this program is burden hours are 257.

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Number of Average burden
pwalker on PROD1PC71 with NOTICES

Number of
Respondents responses per per response
respondents respondent (in hours)

New Enrollees ........................................................................................................................ 100 1 3/60

Laboratory Change Form ...................................................................................................... 20 1 3/60

VerDate Aug<31>2005 19:05 Jul 12, 2007 Jkt 211001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\13JYN1.SGM 13JYN1
 38600 Federal Register / Vol. 72, No. 134 / Friday, July 13, 2007 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Respondents
Laboratory Test Result Form .................................................................................................
Dated: July 9, 2007.
Maryam Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–13605 Filed 7–12–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Childhood
Lead Poisoning Prevention (ACCLPP),
National Center for Environmental
Health (NCEH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting of the
aforementioned committee:
Times and Dates:
8:30 a.m.–5 p.m., September 18, 2007.
8:30 a.m.–12:30 p.m., September 19, 2007.
Place: Radisson Plaza Hotel Minneapolis,
35 South 7th Street, Minneapolis, MN 55402,
Telephone: (612) 339–4900.
Open to the public, limited only by the
space available. The meeting room
accommodates approximately 75 people.
Purpose: The Committee provides advice
and guidance to the Secretary; the Assistant
Secretary for Health; and the Director, CDC,
regarding new scientific knowledge and
technological developments and their
practical implications for childhood lead
poisoning prevention efforts. The Committee
also reviews and reports regularly on
childhood lead poisoning prevention
practices and recommends improvements in
national childhood lead poisoning
prevention efforts.
Matters To Be Discussed: The meeting will
include discussion on the potential
approaches to strengthen existing strategies
to achieve the Healthy People 2010 goal of
eliminating Elevated Blood Lead Levels as a
Public Health Problem in the United States
by 2010, the development of a prevention
based research agenda, and the study designs
related to adverse effects from Blood Lead
Levels (BLLs) < 10 µg/dl; and updates on the
school performance and concurrent BLLs.
Agenda items are subject to change as
pwalker on PROD1PC71 with NOTICES
priorities dictate.
Opportunities will be provided during the
meeting for oral comments. Depending on the
time available and the number of requests, it
may be necessary to limit the time of each
presenter.
VerDate Aug<31>2005 19:05 Jul 12, 2007 Jkt 211001 PO 00000
Contact Person for More Information:
Claudine Johnson, Clerk, Lead Poisoning
Prevention Branch, Division of
Environmental Emergency Health Services,
NCEH, CDC, 4770 Buford Hwy, NE., Mailstop
F–40, Atlanta, GA 30341, Telephone (770)
488–3629, Fax (770) 488–3635.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 6, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–13596 Filed 7–12–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Racial and Ethnic
Approaches to Community Health
Across the United States (REACH US),
Request for Applications (RFA) DP07–
707
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), the Centers for
Disease Control and Prevention (CDC)
announces a meeting of the
aforementioned Special Emphasis
Panel.
Times and Dates: 3 p.m.–8 p.m., July 31,
2007 (Closed), 8 a.m.–5 p.m., August 1, 2007
(Closed), 8 a.m.–5 p.m., August 2, 2007
(Closed), 3 p.m.–8 p.m., August 6, 2007
(Closed), 8 a.m.–5 p.m., August 7, 2007
(Closed), 8 a.m.–5 p.m., August 8, 2007
(Closed), 8 a.m.–5 p.m., August 9, 2007
(Closed).
Place: Sheraton Gateway Hotel Atlanta
Airport, 1900 Sullivan Road, Atlanta, GA
30337, Telephone (800) 454–6835.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Pub. L. 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
Frm 00051 Fmt 4703 Sfmt 4703
Number of Average burden
Number of
responses per per response
respondents respondent (in hours)
754 2 10/60
evaluation of research grant applications in
response to RFA DP07–707, ‘‘Racial and
Ethnic Approaches to Community Health
Across the United States (REACH US).’’
For Further Information Contact: Thijuanie
Lockhart, Program & Management Analyst,
CDC, 4770 Buford Highway, NE., Mail Stop
K–30, Atlanta, GA 30341, Telephone (404)
488–5303.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 9, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–13602 Filed 7–12–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–67776, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 72 FR 35491–35492,
dated June 28, 2007) is amended to
reflect the establishment of the
Extramural Research Program Office
within the National Center for Chronic
Disease Prevention and Health
Promotion, Coordinating Center for
Health Promotion, Centers for Disease
Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows: After the functional statement
for the Program Services Branch
(CUC13), Office of the Director (CUC1),
National Center for Chronic Disease
Prevention and Health Promotion
(CUC), insert the following:
Extramural Research Program Office
(CUC18). The Extramural Research
Program Office (ERPO) plans, develops,
E:\FR\FM\13JYN1.SGM 13JYN1